Cargando…

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

INTRODUCTION: Chronic hepatitis B (CHB) is a prevalent disease associated with high morbidity, mortality, and impact on health care costs. Antiviral therapy is aimed at reducing hepatitis B virus replication in order to limit progressive liver disease and improve the natural history of the disease....

Descripción completa

Detalles Bibliográficos
Autores principales:	Colombo, Giorgio L, Gaeta, Giovanni B, Viganò, Mauro, Di Matteo, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169981/ https://www.ncbi.nlm.nih.gov/pubmed/21935331 http://dx.doi.org/10.2147/CEOR.S16655

Ejemplares similares

A cost-of-illness study of spina bifida in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2013)

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2009)

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
por: Ruggeri, Isabella, et al.
Publicado: (2012)

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
por: Rizzardini, Giuliano, et al.
Publicado: (2012)

Clinical Implications of HBsAg Quantification in Patients with Chronic Hepatitis B
por: Viganò, Mauro, et al.
Publicado: (2012)

Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2008)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)

Cost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective Procedures
por: Mastrorilli, Giulia, et al.
Publicado: (2022)

Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
por: Wu, Bin, et al.
Publicado: (2012)

Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2023)

Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
por: Colombo, Giorgio L, et al.
Publicado: (2008)

Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy
por: Poli, Anna, et al.
Publicado: (2015)

The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis
por: Nyholm, Nanna, et al.
Publicado: (2023)

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy
por: Spandonaro, Federico, et al.
Publicado: (2014)

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
por: Colombo, Giorgio L, et al.
Publicado: (2011)

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2021)

Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
por: Gaeta, Giovanni Battista, et al.
Publicado: (2018)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

The social cost of chronic kidney disease in Italy
por: Turchetti, Giuseppe, et al.
Publicado: (2016)

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy
por: Foo, Jason, et al.
Publicado: (2019)

Cost of persistent asthma in Italy
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
por: Colombo, Giorgio L, et al.
Publicado: (2011)

Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
por: Maggiolo, Franco, et al.
Publicado: (2015)

Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri, Daniela Paola, et al.
Publicado: (2015)

Burden of Crohn’s disease: economics and quality of life aspects in Italy
por: Benedini, Viviano, et al.
Publicado: (2012)

The Search for Cost-Effective Treatment of Chronic Hepatitis B
por: Smith, Vanessa E., et al.
Publicado: (2008)

The cost of the migraine patient in Italy
por: Roncolato, Maurizio, et al.
Publicado: (2000)

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
por: Torre, Enrico, et al.
Publicado: (2022)

Moderate and severe plaque psoriasis: cost-of-illness study in Italy
por: Colombo, GL, et al.
Publicado: (2008)

Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis
por: Stroffolini, Tommaso, et al.
Publicado: (2017)

How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy
por: Taramasso, Lucia, et al.
Publicado: (2018)

Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
por: Colombo, Giorgio L, et al.
Publicado: (2013)

How we make cell therapy in Italy
por: Montemurro, Tiziana, et al.
Publicado: (2015)

Effects of the early phase of the COVID-19 pandemic on natural and ART-mediated birth rates in Lombardy Region, Northern Italy
por: Somigliana, Edgardo, et al.
Publicado: (2021)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tnv5ubv7dlmeu46oslhfmk809s